Skip to content

Comparison of Two Methods for Securing Subcutaneous Access and Their Effects on Comfort and Safety of Patients in Palliative Care

Effects of two Hypodermoclisis fixation techiniques on the occurrence of adverse event, length of stay and their implications for patient comfort in palliative care: randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9krffvx
Enrollment
Unknown
Registered
2025-01-14
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypodermoclysis

Interventions

This is an open, parallel-design, randomized clinical trial with two groups (2x2) to evaluate the effects of the omega technique for fixing the extension device on the occurrence of adverse events and
E07.858.690.800

Sponsors

Universidade Federal de Minas Gerais
Lead Sponsor
Hospital Risoleta Tolentino Neves
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients of both sexes; from 18 years of age; with a medical prescription for hypodermoclysis; who do not have a diagnosis of skin changes; who do not have a known history of allergy to the tape used

Exclusion criteria

Exclusion criteria: Patients who develop an allergy to the tape used; are transferred to another unit will be discontinued from the sample

Design outcomes

Primary

MeasureTime frame
A significant reduction in the occurrence of adverse events related to hypodermoclysis is expected

Secondary

MeasureTime frame
A significant increase in the dwell time of the hypodermoclysis puncture device is expected;A significant increase in the comfort level of patients, as measured by the Edmonton Symptom Assessment System, is expected

Countries

Brazil

Contacts

Public ContactJuliana Coutinho

Universidade Federal de Minas Gerais

jslcoutinho@gmail.com+55(31)985597995

Outcome results

None listed

Source: REBEC (via WHO ICTRP)